GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract HHSN272201700085CFISHER BIOSERVICES, INC.

Overview

Award facts

Net obligations
$24.95M
$24,948,662of $30.54M potential value
Outlays (paid to date)
$7.43M
$7.43M paid of $24.95M obligated$7,425,113
Period of performance
Sep 11, 2017 to Jul 14, 2023
Ended
Modifications
13
Latest action Aug 20, 2026
Contract type
Definitive contract
PIID HHSN272201700085C

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF DIVISION OF MICROBIOLOGY AND INFECTIOUS DISEASES (DMID) CLINICAL MATERIALS SERVICES

Dates and value

Award date
Signed on Sep 11, 2017
Current value
$24,948,662Base and exercised options
Potential value (if all options are exercised)
$30,543,075

Obligations by fiscal year of action

  • FY2026: -$52,431 (de-obligation)
  • FY2023: $867,995
  • FY2021: $5,614,410
  • FY2020: $4,769,067
  • FY2019: $4,353,745
  • FY2018: $5,295,998
  • FY2017: $4,099,878

Total across 7 fiscal years: $24,948,662

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 20, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationROCKVILLE, MD
UEILB4PCGLSJ9E6
CAGE code0M6N4
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
Public health and social services emergency fund; National institute of allergy and infectious diseases (0885)Program activities075-0140, 075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Rockville, Montgomery County, Maryland 20850-5312
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
1

Solicitation and notices

Solicitation ID
NIAIDDMIDNIHAI2016065(as reported)

Contract details

Subcontracting plan
Individual subcontract planF
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 11, 2017Base obligation at award: $4,099,878
Latest action
Aug 20, 2026 — Funding onlyModification P00013; obligation change -$52,431; funding only: changes obligations, not scope
Latest substantive action
Jul 16, 2021 — Option exercisedModification P00009; obligation change +$4,601,795
Latest funding action
Aug 20, 2026 — Funding onlyModification P00013; obligation change -$52,431; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Option exercised5
  • Other administrative action5
  • Funding only3
14 actions recorded, Sep 11, 2017 to Aug 20, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$52,431
Latest action: change in base and all options
-$52,431

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Contingency, humanitarian or peacekeeping operation
Presidential issued emergency declaration, or a major disaster declarationC

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
14

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2017/2017-0885-000
  • 075-2018/2018-0885-000
  • 075-2019/2019-0885-000
  • 075-2020/2020-0885-000
  • 075-2020/2024-0885-000
  • 075-2021/2021-0885-000
Show all 9 accounts
  • 075-2021/2024-0140-000
  • 075-2023/2023-0885-000
  • 075-X-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • U: Emergency P.L. 116-260
COVID-19 supplemental obligations
$2,897,043
COVID-19 supplemental outlays
$2,878,977